CN107118216A - 一种盐酸依匹斯汀杂质b的合成方法 - Google Patents
一种盐酸依匹斯汀杂质b的合成方法 Download PDFInfo
- Publication number
- CN107118216A CN107118216A CN201710319068.XA CN201710319068A CN107118216A CN 107118216 A CN107118216 A CN 107118216A CN 201710319068 A CN201710319068 A CN 201710319068A CN 107118216 A CN107118216 A CN 107118216A
- Authority
- CN
- China
- Prior art keywords
- dibenzo
- azepine
- dihydro
- epinastine hydrochloride
- imidazo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WHWZLSFABNNENI-UHFFFAOYSA-N epinastine Chemical compound C1C2=CC=CC=C2C2CN=C(N)N2C2=CC=CC=C21 WHWZLSFABNNENI-UHFFFAOYSA-N 0.000 title claims abstract description 47
- 229960002548 epinastine hydrochloride Drugs 0.000 title claims abstract description 39
- XUKUURHRXDUEBC-SXOMAYOGSA-N (3s,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-SXOMAYOGSA-N 0.000 title claims abstract description 27
- 238000010189 synthetic method Methods 0.000 title claims abstract description 11
- 238000006243 chemical reaction Methods 0.000 claims abstract description 38
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 claims abstract description 33
- 238000002360 preparation method Methods 0.000 claims abstract description 22
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 claims abstract description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 11
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 claims abstract description 11
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims abstract description 9
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910052794 bromium Inorganic materials 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 7
- 239000000126 substance Substances 0.000 claims abstract description 6
- 230000000977 initiatory effect Effects 0.000 claims abstract description 4
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 54
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 29
- 239000012074 organic phase Substances 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000012065 filter cake Substances 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 15
- 239000007787 solid Substances 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 14
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 10
- 238000007605 air drying Methods 0.000 claims description 10
- 239000008346 aqueous phase Substances 0.000 claims description 10
- 239000012043 crude product Substances 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical group ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 claims description 5
- 235000019345 sodium thiosulphate Nutrition 0.000 claims description 5
- 238000010792 warming Methods 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 230000036571 hydration Effects 0.000 claims 1
- 238000006703 hydration reaction Methods 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 abstract description 7
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 abstract description 7
- 229960003449 epinastine Drugs 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 238000001514 detection method Methods 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 3
- 239000012535 impurity Substances 0.000 abstract description 3
- 238000003908 quality control method Methods 0.000 abstract description 3
- 239000013558 reference substance Substances 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- FAJGWBHDKADUHW-UHFFFAOYSA-N 5h-benzo[c][1]benzazepine Chemical compound N1C=C2C=CC=CC2=CC2=CC=CC=C12 FAJGWBHDKADUHW-UHFFFAOYSA-N 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- FZIPHNWYZRRHKC-UHFFFAOYSA-N 2,4-diazatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),3,6,9,11,14,16-heptaen-3-amine Chemical compound NC1=NCC=2N1C1=C(CC=3C=2CC=CC=3)C=CC=C1 FZIPHNWYZRRHKC-UHFFFAOYSA-N 0.000 description 6
- 125000001246 bromo group Chemical class Br* 0.000 description 3
- 238000005352 clarification Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 206010006482 Bronchospasm Diseases 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- FPKDBVUHIXYLNP-UHFFFAOYSA-N NCC1Nc2ccccc2Cc2ccccc12 Chemical compound NCC1Nc2ccccc2Cc2ccccc12 FPKDBVUHIXYLNP-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 230000007885 bronchoconstriction Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- AJUMGSLQADLWKL-UHFFFAOYSA-N 1h-azepine;hydrochloride Chemical compound Cl.N1C=CC=CC=C1 AJUMGSLQADLWKL-UHFFFAOYSA-N 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- 102100035792 Kininogen-1 Human genes 0.000 description 1
- ULQWSKZYJZDCPP-UHFFFAOYSA-N NC1N2c3ccccc3Cc3ccccc3C2CN1 Chemical compound NC1N2c3ccccc3Cc3ccccc3C2CN1 ULQWSKZYJZDCPP-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 239000002655 kraft paper Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710319068.XA CN107118216B (zh) | 2017-05-08 | 2017-05-08 | 一种盐酸依匹斯汀杂质b的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710319068.XA CN107118216B (zh) | 2017-05-08 | 2017-05-08 | 一种盐酸依匹斯汀杂质b的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107118216A true CN107118216A (zh) | 2017-09-01 |
CN107118216B CN107118216B (zh) | 2019-03-08 |
Family
ID=59726866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710319068.XA Active CN107118216B (zh) | 2017-05-08 | 2017-05-08 | 一种盐酸依匹斯汀杂质b的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107118216B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109856279A (zh) * | 2019-02-22 | 2019-06-07 | 重庆安格龙翔医药科技有限公司 | 使用hplc法分析检测盐酸依匹斯汀颗粒剂中杂质d的方法 |
CN114835712A (zh) * | 2021-02-01 | 2022-08-02 | 重庆恩联生物科技有限公司 | 依匹斯汀的合成方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5312916A (en) * | 1991-01-25 | 1994-05-17 | Boehringer Ingelheim Kg | Process for preparing 3-amino-9,13b-dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepine-hydrochloride |
KR20090050395A (ko) * | 2007-11-15 | 2009-05-20 | 주식회사 참조아 | 6-아미노메틸- 6,11-디하이드로-5H-디벤즈[b,e]아제핀의 제조방법 |
CN103509025A (zh) * | 2012-06-29 | 2014-01-15 | 重庆药友制药有限责任公司 | 一种盐酸依匹斯汀及其中间体的制备方法 |
-
2017
- 2017-05-08 CN CN201710319068.XA patent/CN107118216B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5312916A (en) * | 1991-01-25 | 1994-05-17 | Boehringer Ingelheim Kg | Process for preparing 3-amino-9,13b-dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepine-hydrochloride |
KR20090050395A (ko) * | 2007-11-15 | 2009-05-20 | 주식회사 참조아 | 6-아미노메틸- 6,11-디하이드로-5H-디벤즈[b,e]아제핀의 제조방법 |
CN103509025A (zh) * | 2012-06-29 | 2014-01-15 | 重庆药友制药有限责任公司 | 一种盐酸依匹斯汀及其中间体的制备方法 |
Non-Patent Citations (1)
Title |
---|
DU-JONG BAEK ET AL: "Improvement of the Synthetic Route for Epinastine Antihistamine", 《JOURNAL OF THE KOREAN CHEMICAL SOCIETY》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109856279A (zh) * | 2019-02-22 | 2019-06-07 | 重庆安格龙翔医药科技有限公司 | 使用hplc法分析检测盐酸依匹斯汀颗粒剂中杂质d的方法 |
CN114835712A (zh) * | 2021-02-01 | 2022-08-02 | 重庆恩联生物科技有限公司 | 依匹斯汀的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN107118216B (zh) | 2019-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2231675A1 (en) | Process for the preparation of 5-cyclopropyl-5, 11-dihydro (1) benzoxepino (3, 4-b) -pyridin-5-ol using tmeda | |
CN101607955A (zh) | 一种低残留硫辛酸的制备方法 | |
CN106632548B (zh) | 一种高纯度曲克芦丁及其制备方法 | |
CN107118216B (zh) | 一种盐酸依匹斯汀杂质b的合成方法 | |
CN110240586B (zh) | 2,3-二氢-1H-苯并[f]色满-2-胺衍生物的制备方法 | |
CN105254644B (zh) | 一种米尔贝肟的制备方法 | |
CN106632137A (zh) | 氨噻肟酸乙酯的制备方法 | |
CN104231016A (zh) | 一种硫酸依替米星的制备方法 | |
CN106565675B (zh) | 一种栀子酰胺a-他克林二联体化合物及其制法和应用 | |
CN108929270B (zh) | 一种药物中间体双取代含氮杂环的胺类化合物的合成 | |
CN103467466A (zh) | 一种盐酸莫西沙星杂质的合成方法 | |
CN111333613A (zh) | 一种三氟甲基萘满酮类化合物制备方法 | |
CN101786963B (zh) | 阿扎司琼中间体的合成方法 | |
CN105153143A (zh) | 一种含噁二唑/噻二唑的硫脲嘧啶衍生物及其制备方法和应用 | |
CN106749226A (zh) | 一种avatrombopag马来酸盐晶型C的制备方法 | |
CN103709174B (zh) | 6-溴-3H-恶唑并[4,5-b]吡啶-2-酮的一步合成法 | |
CN109776372A (zh) | 维格列汀有关物质及其制备方法 | |
CN108586560A (zh) | 一种具有降糖活性的苦瓜皂苷和多糖双水相一步提取方法 | |
CN104628720A (zh) | 一种莫西沙星盐酸盐的精制方法 | |
CN103788091A (zh) | 一种制备6-苄基-5,7-二氧代-1,2,3,4-四氢-吡咯并[3,4-b]吡啶的方法及应用 | |
CN103232437B (zh) | 雷贝拉唑钠晶型化合物的制备方法 | |
CN103172638B (zh) | 一种盐酸依匹斯汀的制备方法 | |
CN105985232A (zh) | 一种高含铁量的枸橼酸铁及其制备方法 | |
CN103360457B (zh) | 一种雄甾烷二酮衍生物晶型及其制备方法 | |
CN104693177A (zh) | 一种埃索美拉唑钠的精制方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 314500 518 Tongxiang New Economic Development Zone, Tongxiang Economic Development Zone, Jiaxing, Zhejiang Applicant after: HONGGUAN BIO-PHARMA Co.,Ltd. Address before: 314500 518 Tongxiang New Economic Development Zone, Tongxiang Economic Development Zone, Jiaxing, Zhejiang Applicant before: ZHEJIANG HONGGUAN BIO-PHARMA Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A kind of synthetic method of epilastine hydrochloride impurity B Effective date of registration: 20220831 Granted publication date: 20190308 Pledgee: Bank of Hangzhou Limited by Share Ltd. Tongxiang branch Pledgor: HONGGUAN BIO-PHARMA Co.,Ltd. Registration number: Y2022330001992 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20190308 Pledgee: Bank of Hangzhou Limited by Share Ltd. Tongxiang branch Pledgor: HONGGUAN BIO-PHARMA Co.,Ltd. Registration number: Y2022330001992 |